|
Volumn 85, Issue 1, 2000, Pages 214-218
|
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: A randomized, controlled trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
HOMOCYSTEINE;
PLACEBO;
RALOXIFENE;
ADULT;
AGED;
ARTICLE;
BLOOD LEVEL;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
HORMONE SUBSTITUTION;
HUMAN;
HUMAN EXPERIMENT;
MENOPAUSE;
MULTICENTER STUDY;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
TREATMENT OUTCOME;
AGED;
C-REACTIVE PROTEIN;
DOUBLE-BLIND METHOD;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
FIBRINOGEN;
HOMOCYSTEINE;
HUMANS;
LIPIDS;
MIDDLE AGED;
POSTMENOPAUSE;
PROSPECTIVE STUDIES;
RALOXIFENE;
RISK FACTORS;
EQUIDAE;
|
EID: 0034456409
PISSN: 0021972X
EISSN: None
Source Type: Journal
DOI: 10.1210/jc.85.1.214 Document Type: Article |
Times cited : (354)
|
References (31)
|